245 results on '"Stukas, Sophie"'
Search Results
2. Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population
3. Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study
4. Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality
5. APOE ε4 carrier status modifies plasma p‐tau181 concentrations in cognitively healthy super‐seniors.
6. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
7. APOE4 Carrier Status Modifies Alzheimer’s Disease Plasma Biomarker Concentrations in Healthy Adults Over 85 Years Old
8. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
9. Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort.
10. Brain Hypoxia Is Associated With Neuroglial Injury in Humans Post–Cardiac Arrest
11. An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
12. Association between arterial carbon dioxide, brain biomarkers and central nervous system injury during veno-venous extracorporeal membrane oxygenation: A Prospective Cohort Study.
13. CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
14. Prognostic value of plasma biomarkers in a clinical trial of mild‐to‐moderate Alzheimer's Disease.
15. Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
16. The Association of Inflammatory Cytokines in the Pulmonary Pathophysiology of Respiratory Failure in Critically Ill Patients With Coronavirus Disease 2019
17. Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
18. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
19. Neuroinflammation and the immune system in hypoxic ischaemic brain injury pathophysiology after cardiac arrest.
20. Pediatric Reference Intervals for Serum Neurofilament Light and Glial Fibrillary Acidic Protein
21. The Utility of Blood Based Biomarkers in Detecting Neurological Complications of COVID‐19 in Critically Ill Patients
22. Reference Intervals for Plasma Biomarkers of Alzheimer’s Disease
23. Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes
24. High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
25. Age at injury and genotype modify acute inflammatory and neurofilament-light responses to mild CHIMERA traumatic brain injury in wild-type and APP/PS1 mice
26. Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months.
27. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis
28. Lipids and Lipoproteins in Alzheimer’s Disease
29. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury
30. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
31. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
32. Quantification of neurological blood‐based biomarkers in critically ill patients with COVID‐19
33. Assessing the importance of interleukin-6 in COVID-19
34. Additional file 3 of An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
35. Additional file 2 of An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
36. Additional file 1 of An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
37. Additional file 4 of An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
38. The effects of peripheral lipoprotein metabolism on cerebrovascular inflammation in APP/PS1 mice
39. An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
40. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
41. Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome
42. Increased severity of the CHIMERA model induces acute vascular injury, sub-acute deficits in memory recall, and chronic white matter gliosis
43. Additional file 2: of ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
44. Additional file 5: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
45. Additional file 1: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
46. Additional file 4: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
47. Additional file 2: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
48. Additional file 6: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
49. Additional file 7: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
50. Additional file 3: of CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.